Bausch Health Companies (NYSE:BHC) Posts Earnings Results, Misses Expectations By $0.44 EPS

Bausch Health Companies (NYSE:BHC - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $1.21 earnings per share for the quarter, missing analysts' consensus estimates of $1.65 by ($0.44), Zacks reports. The business had revenue of $2.56 billion for the quarter, compared to analysts' expectations of $2.51 billion. Bausch Health Companies had a negative return on equity of 650.39% and a negative net margin of 0.48%. Bausch Health Companies updated its FY 2025 guidance to EPS.

Bausch Health Companies Price Performance

NYSE:BHC traded up $0.13 during mid-day trading on Friday, hitting $7.31. The company's stock had a trading volume of 3,004,609 shares, compared to its average volume of 3,096,627. The business's fifty day moving average is $7.35 and its two-hundred day moving average is $7.48. The stock has a market cap of $2.64 billion, a price-to-earnings ratio of -60.87, a PEG ratio of 0.38 and a beta of 0.68. Bausch Health Companies has a 1 year low of $3.96 and a 1 year high of $11.46.

Analyst Upgrades and Downgrades

Several analysts have weighed in on BHC shares. StockNews.com raised shares of Bausch Health Companies from a "hold" rating to a "buy" rating in a research report on Friday, October 25th. Royal Bank of Canada cut their target price on Bausch Health Companies from $11.00 to $10.00 and set a "sector perform" rating on the stock in a research report on Thursday, January 30th. Finally, Jefferies Financial Group restated a "hold" rating and issued a $8.00 target price (down previously from $12.00) on shares of Bausch Health Companies in a research note on Thursday, February 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Bausch Health Companies currently has a consensus rating of "Hold" and an average price target of $7.42.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.